Cargando…

Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents

Antcins are newly identified steroid-like compounds from Taiwan’s endemic medicinal mushrooms Antrodia cinnamomea and Antrodia salmonea. Scientific studies of the past two decades confirmed that antcins have various pharmacological activities, including potent anti-oxidant and anti-inflammatory effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Senthil Kumar, K. J., Gokila Vani, M., Hsieh, Han-Wen, Lin, Chin-Chung, Wang, Sheng-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399673/
https://www.ncbi.nlm.nih.gov/pubmed/34451782
http://dx.doi.org/10.3390/plants10081736
_version_ 1783745134385430528
author Senthil Kumar, K. J.
Gokila Vani, M.
Hsieh, Han-Wen
Lin, Chin-Chung
Wang, Sheng-Yang
author_facet Senthil Kumar, K. J.
Gokila Vani, M.
Hsieh, Han-Wen
Lin, Chin-Chung
Wang, Sheng-Yang
author_sort Senthil Kumar, K. J.
collection PubMed
description Antcins are newly identified steroid-like compounds from Taiwan’s endemic medicinal mushrooms Antrodia cinnamomea and Antrodia salmonea. Scientific studies of the past two decades confirmed that antcins have various pharmacological activities, including potent anti-oxidant and anti-inflammatory effects. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the coronavirus disease-2019 (COVID-19) pandemic and is characterized as a significant threat to global public health. It was recently identified that SARS-CoV-2 required angiotensin converting enzyme 2 (ACE2), a receptor which supports host cell entry and disease onset. Here, we report a novel function of antcins, in which antcins exhibit inhibitory effects on ACE2. Compared to the untreated control group, treatment with various antcins (antcin-A, antcin-B, antcin-C, antcin-H, antcin-I, and antcin-M) significantly inhibited ACE2 activity in cultured human epithelial cells. Indeed, among the investigated antcins, antcin-A, antcin-B, antcin-C, and antcin-I showed a pronounceable inhibition against ACE2. These findings suggest that antcins could be novel anti-ACE2 agents to prevent SARS-CoV-2 host cell entry and the following disease onset.
format Online
Article
Text
id pubmed-8399673
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83996732021-08-29 Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents Senthil Kumar, K. J. Gokila Vani, M. Hsieh, Han-Wen Lin, Chin-Chung Wang, Sheng-Yang Plants (Basel) Brief Report Antcins are newly identified steroid-like compounds from Taiwan’s endemic medicinal mushrooms Antrodia cinnamomea and Antrodia salmonea. Scientific studies of the past two decades confirmed that antcins have various pharmacological activities, including potent anti-oxidant and anti-inflammatory effects. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the coronavirus disease-2019 (COVID-19) pandemic and is characterized as a significant threat to global public health. It was recently identified that SARS-CoV-2 required angiotensin converting enzyme 2 (ACE2), a receptor which supports host cell entry and disease onset. Here, we report a novel function of antcins, in which antcins exhibit inhibitory effects on ACE2. Compared to the untreated control group, treatment with various antcins (antcin-A, antcin-B, antcin-C, antcin-H, antcin-I, and antcin-M) significantly inhibited ACE2 activity in cultured human epithelial cells. Indeed, among the investigated antcins, antcin-A, antcin-B, antcin-C, and antcin-I showed a pronounceable inhibition against ACE2. These findings suggest that antcins could be novel anti-ACE2 agents to prevent SARS-CoV-2 host cell entry and the following disease onset. MDPI 2021-08-23 /pmc/articles/PMC8399673/ /pubmed/34451782 http://dx.doi.org/10.3390/plants10081736 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Senthil Kumar, K. J.
Gokila Vani, M.
Hsieh, Han-Wen
Lin, Chin-Chung
Wang, Sheng-Yang
Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents
title Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents
title_full Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents
title_fullStr Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents
title_full_unstemmed Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents
title_short Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents
title_sort antcins from antrodia cinnamomea and antrodia salmonea inhibit angiotensin-converting enzyme 2 (ace2) in epithelial cells: can be potential candidates for the development of sars-cov-2 prophylactic agents
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399673/
https://www.ncbi.nlm.nih.gov/pubmed/34451782
http://dx.doi.org/10.3390/plants10081736
work_keys_str_mv AT senthilkumarkj antcinsfromantrodiacinnamomeaandantrodiasalmoneainhibitangiotensinconvertingenzyme2ace2inepithelialcellscanbepotentialcandidatesforthedevelopmentofsarscov2prophylacticagents
AT gokilavanim antcinsfromantrodiacinnamomeaandantrodiasalmoneainhibitangiotensinconvertingenzyme2ace2inepithelialcellscanbepotentialcandidatesforthedevelopmentofsarscov2prophylacticagents
AT hsiehhanwen antcinsfromantrodiacinnamomeaandantrodiasalmoneainhibitangiotensinconvertingenzyme2ace2inepithelialcellscanbepotentialcandidatesforthedevelopmentofsarscov2prophylacticagents
AT linchinchung antcinsfromantrodiacinnamomeaandantrodiasalmoneainhibitangiotensinconvertingenzyme2ace2inepithelialcellscanbepotentialcandidatesforthedevelopmentofsarscov2prophylacticagents
AT wangshengyang antcinsfromantrodiacinnamomeaandantrodiasalmoneainhibitangiotensinconvertingenzyme2ace2inepithelialcellscanbepotentialcandidatesforthedevelopmentofsarscov2prophylacticagents